Sotera Health Company (SHC) vs Veracyte, Inc. (VCYT)
- Sotera Health Company SHC 17.89 −1.00%
- Veracyte, Inc. VCYT 43.12 −2.86%
Sotera Health Company and Veracyte, Inc. are both Diagnostics & Research companies. Sotera Health Company is the larger, with a market value of $5.2B against $3.6B — 1.4× the size. Veracyte, Inc. trades at the lower P/E: 29.9× against 31.4×. Veracyte, Inc. grew revenue faster over the last twelve months: 17.3% against 8.15%. Veracyte, Inc. has the higher net margin (20.4% vs 13.4%) and the lower return on invested capital (7.32% vs 9.82%). Across the 21 metrics below, Veracyte, Inc. leads on 16 and Sotera Health Company on 5.
Valuation
Profitability
| Metric | SHC | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 54.97% | 71.71% | 50.89% |
| Operating margin | 32.82% | 18.82% | (8.57%) |
| Net margin | 13.44% | 20.37% | (6.37%) |
| Free cash flow margin | 9.27% | 29.54% | 0.00% |
| Return on equity | 27.78% | 8.77% | (2.92%) |
| Return on assets | 5.01% | 8.09% | (6.71%) |
| Return on invested capital | 9.82% | 7.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack